Table 4.

Number of suspected or probable COVID- 19 in patients with hemoglobinopathies in Oman.

Group of patients and demographic data	Age group < 20 yrs (Total no.)	Age group 21–40 yrs (Total no.)	Age group > 40 yrs (Total no.)	Total
1. Thalassemia major (TM) - No.	120	170	10	300
No. of males and No. females	50/70	60/110	5/5	=
Age range	=	=	41–47	=
WHO - Suspected Covid 19 -M/F	3/2	1/0	0/0	6 (2.0%)
WHO - Probable Covid 19 - M/F	1/0	0/0	0/0	1 (0.3%)
2. Thalassemia intermedia (TI) - No.	28	10	6	44
No. of males and No. females	14/14	4/6	5/1	=
Age range	5–20	21–28	41–43	=
WHO - Suspected Covid 19 - M/F	0	0	0	0
WHO - Probable Covid 19 - M/F	0	0	0	0
3. Sickle cell disease (SCD) - No.	800	1,000	200	2,000
No. of males and No. females	430/370	510/490	80/120	=
Age range	=	=	40–61	=
WHO - Suspected Covid 19 - M/F	10/21	20/30	2/3	86 (4.3%)
WHO - Probable Covid 19- M/F	2/0	3/2	0/1	8 (0.4%)